The Emirates Drug Establishment urged the public, particularly people with high cholesterol, to maintain a healthy lifestyle that includes a balanced diet and regular physical activity, and to consult a healthcare professional to assess their condition and determine the most appropriate treatment, helping reduce the risk of cardiovascular disease and promote overall health.
Around 6,600 people in England with a serious heart condition will be able to access a new treatment following simultaneous MHRA authorisation and NICE approval. Aficamten, also known as MYQORZO, is a once-daily pill for people with obstructive hypertrophic cardiomyopathy (HCM) – a condition where the heart muscle becomes thickened and stiff, making it harder for the heart to … Read more
The United States Food and Drug Administration (FDA) last Thursday approved a new daily pill that lowers levels of dangerous cholesterol. The pill is expected to boost compliance rates compared to previously used medications, according to the news release from the University of Maryland Medical System. About a quarter of adults in the US have … Read more